These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4943989)

  • 1. Preventive tolbutamide treatment and arterial disease in mild hyperglycaemia.
    Paasikivi J; Wahlberg F
    Diabetologia; 1971 Oct; 7(5):323-7. PubMed ID: 4943989
    [No Abstract]   [Full Text] [Related]  

  • 2. The UGDP--tolbutamide and mortality.
    Knowles HC
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract]   [Full Text] [Related]  

  • 3. Borderline diabetics and their response to tolbutamide.
    Keen H; Jarrett RJ; Ward JD; Fuller JH
    Adv Metab Disord; 1973; 2():Suppl 2:521-31. PubMed ID: 4720382
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetes mellitus. Present concepts and therapeutic implications].
    de L'Hortet GC; Bercovici JP
    Presse Med (1893); 1968 Dec; 76(50):2389-92. PubMed ID: 5734286
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of patients with abnormal intravenous glucose tolerance after myocardial infarction.
    Paasikivi J
    Adv Metab Disord; 1973; 2():Suppl 2:533-8. PubMed ID: 4720383
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long term effect of tolbutamide on glucose tolerance of asymptomatic and latent diabetics: value of early treatment of diabetes].
    Journ Annu Diabetol Hotel Dieu; 1969; 10():401-5. PubMed ID: 5376997
    [No Abstract]   [Full Text] [Related]  

  • 8. A progress report on the University Group Diabetes Program.
    Prout TE
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):244-51. PubMed ID: 809369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of metabolic adjustment before a new pregnancy. Prophylaxis of congenital malformations.
    Navarrete VN; Paniagua HE; Alger CR; Manzo PB
    Am J Obstet Gynecol; 1970 May; 107(2):250-3. PubMed ID: 5441701
    [No Abstract]   [Full Text] [Related]  

  • 10. Exercise tests in individuals with borderline glucose tolerance and varying smoking habits.
    Persson G
    Acta Med Scand Suppl; 1977; 605():25-37. PubMed ID: 268139
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
    Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
    JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term tolbutamide treatment after myocardial infarction. A clinical and biochemical study of 178 patients without overt diabetes.
    Paasikivi J
    Acta Med Scand Suppl; 1970; 507():1-82. PubMed ID: 4948308
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetic metabolism and arteriosclerosis].
    Trautwein H; Julitz R
    Med Klin; 1973 Apr; 68(15):465-9. PubMed ID: 4696891
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies of latent diabetes mellitus].
    Hanusch AW; Kaiser G
    Z Arztl Fortbild (Jena); 1969 Jan; 63(1):19-25. PubMed ID: 5767547
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy and clinical trials: glycaemia and prevention of macroangiopathy in type 2 diabetes.
    Bolusani H; Peter R; Rees A
    Curr Opin Lipidol; 2008 Dec; 19(6):629-30. PubMed ID: 18957889
    [No Abstract]   [Full Text] [Related]  

  • 16. Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation.
    Sartor G; Scherstén B; Carlström S; Melander A; Nordén A; Persson G
    Diabetes; 1980 Jan; 29(1):41-9. PubMed ID: 7380107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin response to glucose infusion in diabetic and non-diabetic monozygotic twin pairs. Genetic control of insulin response?
    Cerasi E; Luft R
    Acta Endocrinol (Copenh); 1967 Jun; 55(2):330-45. PubMed ID: 5338208
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disputable problems of the effect of sulfanilylurea derivatives in patients with diabetes mellitus and perspectives on their use].
    Baranov VG; Gasparian EG
    Probl Endokrinol (Mosk); 1983; 29(1):3-7. PubMed ID: 6340092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin responses of children with chemical diabetes mellitus.
    Rosenbloom AL
    N Engl J Med; 1970 May; 282(22):1228-31. PubMed ID: 5442631
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of the effects of hypoglycemia agents on vascular complications in patients with adult-onset diabetes. VI. Supplementary report on nonfatal events in patients treated with tolbutamide.
    Diabetes; 1976 Dec; 25(12):1129-53. PubMed ID: 992232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.